GlassScriptPhysician profile
Benny Joe Guzman
NPI 1710988035
$9,186.01
in general payments reported to CMS, 2019-2025
41 companies · $794 in 2025
The $794 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,252 · 2020: $1,168 · 2021: $1,418 · 2022: $2,797 · 2023: $1,025 · 2024: $732 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,551.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $2,040.89 | 2022 | |
| Lilly USA, LLC | $1,025.48 | 2019-2025 | Jardiance, Mounjaro, Emgality |
| Novo Nordisk INC | $962.28 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $723.81 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $717.08 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $596.63 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $403.00 | 2021-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $257.81 | 2019-2025 | Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $255.53 | 2021-2023 | |
| Amarin Pharma, INC. | $252.59 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $215.72 | 2019-2024 | |
| Bausch Health US, LLC | $175.83 | 2019-2022 | |
| Abbott Laboratories | $164.63 | 2022-2024 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $160.43 | 2019-2023 | Belsomra, Steglatro |
| Exact Sciences Corporation | $137.60 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benny Guzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.